All In Biotech

Free tool

FAERS Monitor: Combigan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021398 or its brand name (Combigan, Brimonidine Tartrate, Timolol Maleate). Reports on generic versions are filed under their own applications.

Reports

6,644

Serious

2,704

41% of reports

Hospitalization

1,032

Death reported

318

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • ocular hyperaemia544
  • eye irritation532
  • eye pain481
  • fatigue383
  • drug ineffective365
  • vision blurred341
  • off label use297
  • intraocular pressure increased295
  • dizziness270
  • eye pruritus255
  • headache246
  • diarrhoea215
  • visual impairment211
  • fall199
  • death189

Reports by year received

View as table
YearReports
20051
20062
200713
200840
2009338
2010193
2011224
2012158
2013181
2014213
2015479
2016695
2017602
2018611
2019555
2020561
2021453
2022369
2023305
2024257
2025266
2026128

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,515 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal29574.866.820,918
ocular hyperaemiaSignal54436.733.818,680
eye irritationSignal53229.527.214,537
eye painSignal48127.225.012,048
eye pruritusSignal25524.221.45,615
vision blurredSignal3417.97.12,049
visual impairmentSignal2115.44.7755
fall1991.91.784
dizziness2701.71.581
fatigue3831.61.479
headache2461.21.112
off label use2971.11.01
diarrhoea2151.10.91
drug ineffective3650.90.87
death1890.70.626

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.